Publication:
Polygenic Risk Scores for Atherosclerotic Cardiovascular Disease in the Asia-Pacific Region

dc.contributor.authorHayato Tadaen_US
dc.contributor.authorKhung Keong Yeoen_US
dc.contributor.authorJian Jun Lien_US
dc.contributor.authorKathryn Tanen_US
dc.contributor.authorJunya Akoen_US
dc.contributor.authorRungroj Krittayaphongen_US
dc.contributor.authorRu San Tanen_US
dc.contributor.authorPhilip E. Aylwarden_US
dc.contributor.authorCarolyn S.P. Lamen_US
dc.contributor.authorSang Hong Baeken_US
dc.contributor.authorJamshed Dalalen_US
dc.contributor.authorAlan Fongen_US
dc.contributor.authorYi Heng Lien_US
dc.contributor.authorRichard C. O'Brienen_US
dc.contributor.authorSi Ya Natalie Kohen_US
dc.contributor.authorDaniel J. Schereren_US
dc.contributor.authorVernon Kangen_US
dc.contributor.authorAdam J. Nelsonen_US
dc.contributor.authorJulie Buttersen_US
dc.contributor.authorStephen J. Nichollsen_US
dc.contributor.otherSiriraj Hospitalen_US
dc.contributor.otherKanazawa University Graduate School of Medical Sciencesen_US
dc.contributor.otherSouth Australian Health and Medical Research Instituteen_US
dc.contributor.otherNational Cheng Kung University Hospitalen_US
dc.contributor.otherFuwai Hospital, Chinese Academy of Medical Sciences & Peking Union Medical Collegeen_US
dc.contributor.otherUniversity of Melbourneen_US
dc.contributor.otherFlinders Universityen_US
dc.contributor.otherMonash Universityen_US
dc.contributor.otherSarawak General Hospitalen_US
dc.contributor.otherThe University of Hong Kongen_US
dc.contributor.otherKitasato Universityen_US
dc.contributor.otherNational Heart Centre, Singaporeen_US
dc.contributor.otherThe Catholic University of Korea, College of Medicineen_US
dc.contributor.otherSingapore Heart Foundationen_US
dc.contributor.otherKokilaben Hospitalen_US
dc.date.accessioned2022-08-04T08:58:11Z
dc.date.available2022-08-04T08:58:11Z
dc.date.issued2021-12-01en_US
dc.description.abstractApproximately one-half of the phenotypic susceptibility to atherosclerotic cardiovascular disease (ASCVD) has a genetic basis. Although individual allelic variants generally impart a small effect on risk for ASCVD, an emerging body of data has shown that the aggregation and weighting of many of these genetic variations into “scores” can further discriminate an individual's risk beyond traditional risk factors alone. Consistent with the theory of population genetics, such polygenic risk scores (PRS) appear to be ethnicity specific because their elements comprise single-nucleotide variants that are always ethnicity specific. The currently available PRS are derived predominantly from European ancestry and thus predictably perform less well among non-European participants, a fact that has implications for their use in the Asia-Pacific region. This paper describes the current state of knowledge of PRS, the available data that support their use in this region, and highlights the needs moving forward to safely and effectively implement them in clinical care in the Asia-Pacific region.en_US
dc.identifier.citationJACC: Asia. Vol.1, No.3 (2021), 294-302en_US
dc.identifier.doi10.1016/j.jacasi.2021.08.008en_US
dc.identifier.issn27723747en_US
dc.identifier.other2-s2.0-85132177662en_US
dc.identifier.urihttps://repository.li.mahidol.ac.th/handle/20.500.14594/77412
dc.rightsMahidol Universityen_US
dc.rights.holderSCOPUSen_US
dc.source.urihttps://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85132177662&origin=inwarden_US
dc.subjectMedicineen_US
dc.titlePolygenic Risk Scores for Atherosclerotic Cardiovascular Disease in the Asia-Pacific Regionen_US
dc.typeReviewen_US
dspace.entity.typePublication
mu.datasource.scopushttps://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85132177662&origin=inwarden_US

Files

Collections